The two-day gathering departs from traditional conference formats, opting for immersive, collaborative dialogues between attendees and researchers. Co-chaired by Dr. Laura Carstensen of the Stanford Center on Longevity and Dr. Eric Verdin of the Buck Institute, the program features high-profile contributors including Dr. Robert Waldinger of Harvard Medical School and lifestyle medicine pioneer Dr. Dean Ornish. These experts intend to bridge the gap between academic research and practical daily health habits.

Beyond the headliners, the agenda covers a spectrum of aging science, from the biology of stem cells to the integration of artificial intelligence in personalized medicine. Dr. Nathan Price and Dr. Mike Stone will lead sessions on translating biomarker data into actionable wellness routines, while other panels explore the critical roles of sleep and technology in healthspan optimization. Attilio CEO Paul A. Pagnato emphasizes that the mission is to make advanced longevity care accessible to a broader population, operating under strict Conflict-Free Standards that prohibit revenue sharing and self-dealing.